£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

India Cancer Supportive Care Drugs Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 19 days · 19 data points (no recent data)

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 03 August 2026 07 August 2026 12 August 2026 16 August 2026 21 August 2026
View at Amazon ↗

Price data last checked 72 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 19 days • 1 price levels

Days at Price
19 days 0 5 10 14 19 £515 Days at Price

Price Analysis

Most common price: £515 (19 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 19 days

Description

This comprehensive study provides a detailed outlook for the cancer supportive care drug market in India from 2023 to 2028. It focuses on latent demand across various states, union territories, and cities to help professionals understand potential industry earnings (P.I.E.). With data covering over 4,900 cities, the report offers comparative benchmarks by showing each city's percent share of its state, union territory, and India as a whole. This statistical approach provides a foundation for developing effective distribution and sales force strategies through econometric analysis.

Key Features

Covers the latent demand outlook for cancer supportive care drugs across India from 2023 to 2028.

Provides potential industry earnings (P.I.E.) estimates in millions of U.S. dollars.

Includes detailed data for over 4,900 cities throughout India's states and union territories.

Offers comparative benchmarks by reporting the percent share of cities relative to their states and the nation.

Supports the development of sales force and distribution strategies through econometric analysis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
29 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
99% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
99% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
99% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 23 Sep 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
99% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan

£495.00 02 Oct 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
98% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 20 Aug 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
98% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 31 Oct 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
98% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in India
98% match

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in India

£515.00 15 Aug 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
98% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 15 Aug 2026
The 2025-2030 World Outlook for Cancer Therapies
98% match

The 2025-2030 World Outlook for Cancer Therapies

Price unavailable
The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
98% match

The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City

£795.00 02 Oct 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India
98% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in India

£515.00 22 Aug 2026
Cancer Therapy Outlook 2016-2021 - North America & Caribbean
98% match

Cancer Therapy Outlook 2016-2021 - North America & Caribbean

£425.00 22 Aug 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
98% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£520.00 21 Aug 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India

£515.00 20 Aug 2026
Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study
98% match

Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study

£425.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Vaccines in India
98% match

The 2023-2028 Outlook for Cancer Vaccines in India

£515.00 01 Oct 2026
The 2025-2030 World Outlook for Cancer Specialty Hospitals
98% match

The 2025-2030 World Outlook for Cancer Specialty Hospitals

Price unavailable
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
98% match

Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028

£515.00 22 Aug 2026
The 2025-2030 World Outlook for Immune-Oncology Treatments
98% match

The 2025-2030 World Outlook for Immune-Oncology Treatments

£790.00 25 Aug 2026